Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound ... of Wegovy and Zepbound when there was a ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...

The WHO continues to probe COVID-19 origins, yet critical information is lacking. Meanwhile, individuals like Amy Spencer are ...